PlumX Metrics
Embed PlumX Metrics

Naloxegol for opioid-induced constipation

Drug and Therapeutics Bulletin, ISSN: 1755-5248, Vol: 53, Issue: 12, Page: 138-140
2015
  • 2
    Citations
  • 0
    Usage
  • 17
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

▼Naloxegol (Moventig-AstraZeneca) is a peripherally acting mu-opioid receptor antagonist licensed for the treatment of opioid-induced constipation in adults who have had an inadequate response to laxative treatment. It was launched in the United Kingdom in October 2015. Here, we review the evidence for naloxegol and consider its place in the management of opioid-induced constipation.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know